Epilepsy Trial, Recruiting NCT00060541 Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT00060541
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 4 years of age or older
  • You must be seeking care from, or be referred to, the Surgical Neurology Branch for a brain or nervous system condition — such as brain tumors, nerve tumors, epilepsy, Parkinson's disease, movement disorders, Chiari syndrome, nervous system malformations, or pain disorders
  • Adults must be able to give their own consent, or have a legal representative who can give consent on their behalf if they are unable to do so
  • Children must have a parent or legal guardian who can give consent on their behalf
  • If you are a blood relative of someone being tested for a possible genetic cause of their neurological condition, you may be eligible for the genetic testing part of the trial
  • If you are only providing a skin sample or saliva sample, you must also be willing to agree to the collection of your health information or biological samples, including storage of those samples

Who may not be able to join:

  • People who are unable to undergo assessment and treatment for a brain or nervous system condition
  • For those only providing skin or saliva samples: people who do not yet have a clear, established diagnosis of a recognized condition with known treatment guidelines, if the researchers feel that enrolling them would not meaningfully advance medical knowledge (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: John D Heiss, M.D., National Institute of Neurological Disorders and Stroke (NINDS)

Phone: (301) 496-2921

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 June 2003

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

standard clinical evaluation and treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov